Logo for LaunchBio Program: Investor ConnectLogo for LaunchBio Program: Investor Connect

Bridging the gap between innovation and capital

Online

Portal Innovations

Early stage biotech; pre-clinical therapeutic; diagnostic; medical device companies

Program

Calling all early stage biotech; pre-clinical therapeutic; diagnostic; medical device companies!

Portal Innovations is a venture capital firm that helps exceptional life sciences innovators build their companies where they live. They surround these entrepreneurs with the resources and community they need: seed capital, fully equipped lab space, and expertise and introductions to other investors and partners.

Event

LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Portal Innovations.

Applications will be selected based on meeting the following criteria:

Geography:
A presence in or near Portal’s locations – Atlanta, Boston, Chicago, and Houston

Company type:
Early-stage biotech companies developing therapeutics, diagnostics, or medical devices.

Milestones anticipated:

  • Asset-focused therapeutic companies with strong in vivo data, to fund hit-to-lead and IND-enabling studies.
  • Platform-focused therapeutic companies with disruptive technology, to validate and expand platforms and nominate lead assets. 
  • Diagnostic and medical device companies addressing large unmet medical needs and markets with strong in vivo data, to fund design, manufacturing, and clinical testing.


Stage:
Seed rounds are the sweet spot, but also companies seeking pre-seed, seed, and series A funding.

 

Qualifying start-ups can apply here today. Applications are accepted on a rolling basis.
Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.

Partners